Results 181 to 190 of about 19,560 (233)

Antiangiogenic Drugs in Age Related Macular Degeneration: evidence based medicine and off-label use [PDF]

, 2011
Cachulo, ML, Faria de Abreu, JR, Figueira, J, Fonseca, P, Murta, JN, Pires, I, Silva, R   +6 more
core  

The macular microvascular changes in children with a history of retinopathy of prematurity treated with intravitreal Bevacizumab injection using optical coherence tomography angiography: a retrospective cohort. [PDF]

BMC Ophthalmol
Eftekhari Milani A, Ahoor MH, Etemad F, Kharrazi Ghadim B, Arasteh A.   +4 more
europepmc   +1 more source

Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity. [PDF]

BMC Ophthalmol
Minturn R, Hartigan K, Vegunta S, Boente C, Golzarri-Arroyo L, Hynes E, Laughlin E, Haider K, Kua KL.   +8 more
europepmc   +1 more source

Real-life neovascular AMD treatment considering reimbursement in Turkiye: One-year comparison of switching to intravitreal ranibizumab or aflibercept after treatment failure with three loading intravitreal bevacizumab injections. [PDF]

North Clin Istanb
Sevik MO, Tiras NZ, Aykut A, Yigit DD, Sahin O.   +4 more
europepmc   +1 more source

Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial. [PDF]

J Ophthalmic Vis Res
Ramezani A, Molazem H, Entezari M, Nikkhah H, Saman Rezanejad MD, Yaseri M.   +5 more
europepmc   +1 more source

Combined use of intravitreal bevacizumab and oral steroid treatment in three diabetic papillopathy patients: a diagnostic and treatment challenge.

GMS Ophthalmol Cases
Taşkıran Kandeğer B, Argun M, Tök L, Tök Ö.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of Intravitreal Bevacizumab (Avastin)

Ophthalmology, 2007
To describe the pharmacokinetics of 1.25 mg of intravitreal bevacizumab (Avastin).Experimental animal study.Twenty Dutch-belted rabbits.One eye of each of 20 rabbits was injected with 1.25 mg of intravitreal bevacizumab. Both eyes of each of 4 rabbits were enucleated at days 1, 3, 8, 15, and 29. Bevacizumab concentrations were measured in aqueous fluid,
Sophie J, Bakri, Melissa R, Snyder, Joel M, Reid, Jose S, Pulido, Ravinder J, Singh   +4 more
openaire   +4 more sources

INTRAVITREAL BEVACIZUMAB DURING PREGNANCY

Retina, 2010
To report the clinical course of four women treated with intravitreal bevacizumab during pregnancy.Observational case series.Four pregnant women were treated with intravitreal bevacizumab for choroidal neovascularization (CNV) because of presumed ocular histoplasmosis syndrome punctate inner choroidopathy, or sarcoid uveitis.
Ryan M, Tarantola, James C, Folk, H Culver, Boldt, Vinit B, Mahajan   +3 more
openaire   +2 more sources

Intravitreal Bevacizumab for Diabetic Papillopathy

Journal of Ocular Pharmacology and Therapeutics, 2010
A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect.
Örnek, Kemal, Oğurel, Tevfik
openaire   +3 more sources

Angioedema after intravitreal bevacizumab injection

Cutaneous and Ocular Toxicology, 2012
A 47-year-old male with a history of diabetes mellitus type 2 exhibited with decreased vision in both eyes. The diagnosis of cystoid macular edema (CME) was made and it was decided to administer bilateral intravitreal bevacizumab (Avastin) injections. After intravitreal bevacizumab injection (1.25 mg/0.05 cc) to the right eye the patient had angioedema
Yasin, Toklu, Ozge, Sarac, Sule, Berk, Saban, Simsek   +3 more
openaire   +2 more sources